Related Experiment Video
Updated: Jan 5, 2026

09:15
Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine
Published on: February 24, 2023
3.8K
Boosting Antitumour Immunity through Targeted Delivery of Interferon-α.
Paul J Fairchild1, Timothy J Davies1
1University of Oxford, Sir William Dunn School of Pathology, South Parks Road, Oxford, OX1 3RE, UK.
Trends in Molecular Medicine
|October 19, 2019
Summary
Induced pluripotent stem cells (iPSCs) offer a novel method for targeted delivery of interferon-alpha (IFNα) in cancer immunotherapy. This approach aims to enhance existing anti-tumour immune responses, improving treatment efficacy.
Area of Science:
- Oncology
- Immunology
- Stem Cell Biology
Background:
- Cancer immunotherapy, particularly immune checkpoint inhibitors (ICIs), has transformed treatment by leveraging the patient's immune system.
- The efficacy of ICIs relies on pre-existing anti-tumour immune responses, which are not always sufficient for complete tumour eradication.
Purpose of the Study:
- To investigate the potential of induced pluripotent stem cells (iPSCs) for targeted delivery of therapeutic agents in cancer immunotherapy.
- To explore the use of iPSCs to deliver interferon-alpha (IFNα) to enhance anti-tumour immune responses.
Main Methods:
- Utilizing the unique properties of iPSCs for targeted delivery systems.
- Employing interferon-alpha (IFNα) as a therapeutic payload delivered by iPSCs.
Main Results:
- The study by Tsuchiya et al. proposes a novel strategy using iPSCs.
- This method aims to concentrate IFNα at the tumour site, potentially amplifying the immune response.
Conclusions:
- Exploiting iPSC properties may provide a new avenue for improving cancer immunotherapy efficacy.
- Targeted delivery of IFNα via iPSCs could overcome limitations of current immunotherapies by boosting anti-tumour immunity.
Related Concept Videos
Tumor Immunotherapy
1.7K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
1.7K
Targeted Cancer Therapies
8.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
8.6K
Combination Therapies and Personalized Medicine
5.8K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.8K
Cancer Vaccines
913
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
913
Immune Response Against Viral Pathogens
1.6K
The immune system's response to viral infections is a complex and coordinated process involving natural killer (NK) cells, T cell-mediated responses, and antibody-mediated responses.
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...
1.6K

